Intensive Care Medicine

, Volume 26, Supplement 3, pp S400–S404

The Recent Development of Propofol (DIPRIVAN®)

  • K. A. Thompson
  • David B. Goodale
ORIGINAL

DOI: 10.1007/PL00003783

Cite this article as:
Thompson, K. & Goodale, D. Intensive Care Med (2000) 26(Suppl 3): S400. doi:10.1007/PL00003783

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • K. A. Thompson
    • 1
  • David B. Goodale
    • 1
  1. 1.AstraZeneca, 1800 Concord Pike-DCC1, PO Box 15437, Wilmington, DE 19850–5437 Tel.: + 3 02-8 86-79 50 Fax: + 3 02-8 86-10 93